Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen J Forman

Showing results (411-420 of 504) with videos related to

Pageof 51
Sort By:
Journal of Hematology & Oncology|June 30, 2018
Multi-center phase II trial of bortezomib and rituximab maintenance combination therapy in patients with mantle cell lymphoma after consolidative autologous stem cell transplantationRobert W Chen, Joycelynne M Palmer, Sarah Tomassetti, et al.
Cancers|December 17, 2024
Combined Cytokine Blockade Therapy (CCBT) Using Basiliximab and Infliximab for Treatment of Steroid-Refractory Graft-Versus-Host Disease (SR-GvHD)Hoda Pourhassan, Tina Nguyen, Dongyun Yang, et al.
Transplantation and Cellular Therapy|November 12, 2023
Sirolimus Is an Acceptable Alternative to Tacrolimus for Graft-versus-Host Disease Prophylaxis after Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplantation CyclophosphamideHany Elmariah, Salman Otoukesh, Ambuj Kumar, et al.
Blood|June 15, 2016
Autologous hematopoietic cell transplantation for HIV-related lymphoma: results of the BMT CTN 0803/AMC 071 trialJoseph C Alvarnas, Jennifer Le Rademacher, Yanli Wang, et al.
Blood Advances|October 20, 2017
US Intergroup Study of Chemotherapy Plus Dasatinib and Allogeneic Stem Cell Transplant in Philadelphia Chromosome Positive ALLFarhad Ravandi, Megan Othus, Susan M O'Brien, et al.
Biorxiv : the Preprint Server for Biology|July 12, 2026
Focal radiotherapy improves CAR T cell therapy targeting prostate cancerCari A Young, Jiangyue Liu, Yuwei Ren, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 1, 2021
Pre-conditioning modifies the TME to enhance solid tumor CAR T cell efficacy and endogenous protective immunityJohn P Murad, Dileshni Tilakawardane, Anthony K Park, et al.
Cancer Cell|November 16, 2016
A Druggable TCF4- and BRD4-Dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell NeoplasmMichele Ceribelli, Zhiying Esther Hou, Priscilla N Kelly, et al.
Human Mutation|December 17, 2008
Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1Frederick S Kaplan, Meiqi Xu, Petra Seemann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 9, 2022
Trends in Late Mortality and Life Expectancy After Autologous Blood or Marrow Transplantation Over Three Decades: A BMTSS ReportSmita Bhatia, Chen Dai, Wendy Landier, et al.
Pageof 51

Showing results (411-420 of 504) with videos related to

Sort By:
Pageof 51
Journal of Hematology & Oncology|June 30, 2018
Multi-center phase II trial of bortezomib and rituximab maintenance combination therapy in patients with mantle cell lymphoma after consolidative autologous stem cell transplantationRobert W Chen, Joycelynne M Palmer, Sarah Tomassetti, et al.
Cancers|December 17, 2024
Combined Cytokine Blockade Therapy (CCBT) Using Basiliximab and Infliximab for Treatment of Steroid-Refractory Graft-Versus-Host Disease (SR-GvHD)Hoda Pourhassan, Tina Nguyen, Dongyun Yang, et al.
Transplantation and Cellular Therapy|November 12, 2023
Sirolimus Is an Acceptable Alternative to Tacrolimus for Graft-versus-Host Disease Prophylaxis after Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplantation CyclophosphamideHany Elmariah, Salman Otoukesh, Ambuj Kumar, et al.
Blood|June 15, 2016
Autologous hematopoietic cell transplantation for HIV-related lymphoma: results of the BMT CTN 0803/AMC 071 trialJoseph C Alvarnas, Jennifer Le Rademacher, Yanli Wang, et al.
Blood Advances|October 20, 2017
US Intergroup Study of Chemotherapy Plus Dasatinib and Allogeneic Stem Cell Transplant in Philadelphia Chromosome Positive ALLFarhad Ravandi, Megan Othus, Susan M O'Brien, et al.
Biorxiv : the Preprint Server for Biology|July 12, 2026
Focal radiotherapy improves CAR T cell therapy targeting prostate cancerCari A Young, Jiangyue Liu, Yuwei Ren, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 1, 2021
Pre-conditioning modifies the TME to enhance solid tumor CAR T cell efficacy and endogenous protective immunityJohn P Murad, Dileshni Tilakawardane, Anthony K Park, et al.
Cancer Cell|November 16, 2016
A Druggable TCF4- and BRD4-Dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell NeoplasmMichele Ceribelli, Zhiying Esther Hou, Priscilla N Kelly, et al.
Human Mutation|December 17, 2008
Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1Frederick S Kaplan, Meiqi Xu, Petra Seemann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 9, 2022
Trends in Late Mortality and Life Expectancy After Autologous Blood or Marrow Transplantation Over Three Decades: A BMTSS ReportSmita Bhatia, Chen Dai, Wendy Landier, et al.
Pageof 51